PDCD1 and digestive system mixed adenoneuroendocrine carcinoma: While surgical resection remains the first choice for the treatment of MANEC without distant metastasis, new modalities such as anti-PD-1 monoclonal antibodies may be considered for advanced MANEC with MSI-high.